Asterios Karagiannis Selected Research

Asterios Karagiannis Research Topics

Disease

27	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 03/2007
25	Hypertension (High Blood Pressure) 03/2022 - 08/2005
24	Non-alcoholic Fatty Liver Disease 01/2021 - 05/2006
20	Type 2 Diabetes Mellitus (MODY) 10/2022 - 05/2007
20	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 01/2007
19	Heart Failure 01/2022 - 04/2007
17	Coronary Disease (Coronary Heart Disease) 01/2019 - 01/2007
14	Obesity 03/2022 - 08/2005
14	Stroke (Strokes) 01/2022 - 07/2007
13	Diabetes Mellitus 01/2022 - 06/2008
10	Atherosclerosis 03/2022 - 04/2007
10	Dyslipidemias (Dyslipidemia) 07/2021 - 06/2008
9	Chronic Renal Insufficiency 01/2022 - 07/2009
8	Inflammation (Inflammations) 03/2022 - 09/2008
7	Alcoholic Fatty Liver 01/2021 - 08/2012
6	Coronary Artery Disease (Coronary Atherosclerosis) 02/2015 - 05/2007
5	Insulin Resistance 03/2022 - 11/2010
5	Ischemic Stroke 01/2019 - 01/2004
4	Myocardial Infarction 01/2022 - 11/2007
4	Body Weight (Weight, Body) 12/2019 - 05/2006
4	Hyperaldosteronism (Conn Syndrome) 01/2018 - 01/2007
4	Vascular Diseases (Vascular Disease) 01/2016 - 01/2009
4	Acute Coronary Syndrome 02/2015 - 01/2009
4	Obstructive Sleep Apnea 09/2014 - 01/2014
4	Abdominal Obesity 12/2010 - 02/2007
3	COVID-19 01/2022 - 11/2021
3	Infections 11/2021 - 01/2017
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 01/2017
3	Weight Loss (Weight Reduction) 12/2020 - 05/2007
3	Crohn Disease (Crohn's Disease) 01/2016 - 07/2014
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016 - 07/2014
3	Ulcerative Colitis 01/2016 - 07/2014
3	Atherosclerotic Plaque (Atheroma) 01/2015 - 03/2007
3	Essential Hypertension 02/2014 - 09/2006
3	Unstable Angina 09/2013 - 11/2007
3	Necrosis 01/2013 - 01/2010
2	Systemic Scleroderma (Systemic Sclerosis) 12/2021 - 12/2020
2	Diabetes Complications 11/2021 - 01/2014
2	Hypercholesterolemia 07/2021 - 02/2008
2	Liver Diseases (Liver Disease) 01/2019 - 02/2014
2	Fibrosis (Cirrhosis) 01/2019 - 01/2018
2	Proteinuria 01/2019 - 01/2015
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2018 - 03/2008
2	Homozygous Familial Hypercholesterolemia 01/2018 - 01/2014
2	Weight Gain 01/2018 - 03/2008
2	Hyperkalemia 01/2018 - 05/2005
2	Fatty Liver 01/2018 - 01/2018
2	Alcoholism (Alcohol Abuse) 07/2015 - 02/2014

Drug/Important Bio-Agent (IBA)

53	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2021 - 01/2007
21	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2005
21	Atorvastatin (Lipitor)FDA Link 07/2021 - 05/2006
18	LipidsIBA 07/2021 - 03/2007
12	LDL CholesterolIBA 03/2018 - 05/2006
12	Uric Acid (Urate)IBA 12/2017 - 05/2005
11	Pharmaceutical PreparationsIBA 11/2021 - 08/2005
10	oxidized low density lipoproteinIBA 03/2018 - 03/2007
10	Triglycerides (Triacylglycerol)IBA 03/2018 - 05/2006
9	Metformin (Glucophage)FDA LinkGeneric 11/2021 - 05/2006
8	SodiumIBA 01/2022 - 01/2016
7	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2022 - 01/2016
7	AdipokinesIBA 03/2022 - 01/2010
7	CholesterolIBA 01/2019 - 05/2006
7	HDL CholesterolIBA 03/2018 - 01/2007
6	Rosuvastatin Calcium (Crestor)FDA Link 07/2021 - 07/2009
6	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 02/2007
5	Ezetimibe (Zetia)FDA Link 07/2021 - 02/2008
5	C-Reactive ProteinIBA 01/2019 - 05/2006
5	Fibric Acids (Fibrates)IBA 03/2018 - 01/2009
4	AdiponectinIBA 10/2018 - 05/2007
4	AldosteroneIBA 10/2018 - 09/2008
4	EnzymesIBA 01/2018 - 12/2010
4	Spironolactone (Aldactone)FDA LinkGeneric 01/2018 - 01/2007
4	Pioglitazone (Actos)FDA Link 01/2018 - 03/2008
4	MicroRNAs (MicroRNA)IBA 01/2016 - 01/2014
4	Vitamin D FDA LinkGeneric 05/2014 - 09/2010
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 12/2019
3	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2018
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 03/2008
3	Atenolol (Tenormin)FDA LinkGeneric 02/2014 - 09/2006
3	aliskiren FDA Link 02/2014 - 04/2007
3	CytokinesIBA 01/2014 - 01/2014
3	Orlistat (Xenical)FDA Link 11/2011 - 05/2006
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2010 - 04/2007
2	Drug CombinationsIBA 07/2021 - 01/2011
2	SymportersIBA 01/2021 - 01/2016
2	dapagliflozinIBA 01/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 12/2020 - 05/2006
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020 - 01/2016
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019 - 08/2009
2	Nebivolol FDA Link 01/2019 - 02/2014
2	mipomersenIBA 01/2018 - 01/2014
2	Vitamin E FDA LinkGeneric 01/2018 - 01/2018
2	BMS201038IBA 01/2018 - 01/2014
2	Proprotein Convertase 9IBA 01/2017 - 01/2015

Therapy/Procedure

15	Therapeutics 01/2021 - 05/2005
7	Secondary Prevention 12/2018 - 10/2007
5	Drug Therapy (Chemotherapy) 12/2020 - 10/2011
4	Renal Dialysis (Hemodialysis) 12/2020 - 01/2008
4	Percutaneous Coronary Intervention 01/2016 - 04/2010
3	Glycemic Control 12/2019 - 05/2007